mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
Originally reported by Ars Technica
Read original
The vaccine reportedly thwarted the cancer's return and spread.
